Patents in Months, Not Years: The ROI of Track 1 for High-Growth Companies

In fiscal year 2026, Track 1 applications reached a final disposition an average of 4.9 months after the USPTO granted the Track 1 request, and granting the request took about 2 months from filing (USPTO Track One dashboard). Regular applications averaged 28.8 months of total pendency (USPTO pendency data). This isn’t marketing hyperbole; it’s USPTO data showing how prioritized examination has fundamentally changed patent timelines for companies willing to pay premium fees.

For biotechnology startups, this timeline compression can significantly impact their survival. Between 2011 and 2022, 27% of all patents on small-molecule drugs and 51% of patents on biologic drugs were granted via Track 1. Pharmaceutical companies have discovered that controlling patent timing enables strategic market positioning worth millions in extended exclusivity.

Whether you’re protecting breakthrough AI algorithms before competitors catch up or securing SaaS innovations to attract Series A funding, understanding Track 1’s mechanics, costs, and strategic applications determines whether you’ll control your market timing or watch opportunities slip away during standard examination delays.

What Track 1 Prioritized Examination Actually Delivers

Track 1 prioritized examination, formally known as the “Track One Prioritized Examination Program,” is the USPTO’s primary mechanism for expediting the review of patent applications. Established under the America Invents Act in 2011 and codified at 37 C.F.R. §1.102(e), this program transforms patent prosecution from a multi-year waiting game into a predictable 12-month process.

The core mechanism works like priority boarding at airports – you pay extra to skip the regular queue. Upon grant of a Track 1 request, the application is accorded special status and immediately placed on an examiner’s high-priority docket, bypassing much of the typical waiting period.

For software and AI innovators, this acceleration is particularly crucial. Technology moves fast, and waiting 2-3 years for patent protection can mean your innovation is already obsolete or widely copied. Track 1 lets you secure enforceable rights while your technology still delivers a competitive advantage.

Timeline Compression: The Real Numbers

The time savings are substantial across every examination phase:

The USPTO’s goal is a final disposition (allowance, final rejection, or abandonment) within about 12 months. In practice, most prioritized applications move much faster.

Quality Maintains Despite Speed

The USPTO does not cut corners on the examination itself – the same patentability criteria and quality reviews apply.

Track 1 Filing Requirements: What Qualifies and What Doesn’t

Success in Track 1 depends on meeting specific eligibility criteria that distinguish it from standard patent filing procedures.

Strict Claim Limitations

A Track 1 request will be granted only if the application contains no more than four independent claims and a total of 30 claims, and no multiple-dependent claims. These limits must be maintained throughout the prosecution – exceeding them during amendment results in the loss of Track 1 status.

The rationale is efficiency. Smaller claim sets are quicker to examine, enabling the USPTO to meet the fast timeline. Applicants are thus encouraged to focus on their most essential claims in the Track 1 application.

This claim limitation strategy aligns well with modern software patent drafting. Rather than claiming every possible variation, focus on your core innovation – the unique algorithm, the novel data structure, the distinctive user interface element that gives you a competitive advantage. Additional variations can be pursued through continuation applications if needed.

Eligible vs. Excluded Applications

Eligible Applications:

• Original (non-provisional) utility patent applications and plant patent applications filed under 35 U.S.C. 111(a).
• Continuation and divisional applications can also be filed with Track 1 requests, provided they meet all criteria.
• A Track 1 request can also be filed with or after a Request for Continued Examination (RCE), before the first Office action on the RCE; only one such request is granted per application (37 C.F.R. § 1.102(e)(2)).

Excluded Applications:

• Design applications are not eligible for Track 1 (37 C.F.R. § 1.102(e)). The USPTO also ended its separate expedited (“rocket docket”) examination of design applications in 2025, leaving an Accelerated Examination petition as the faster route for designs (USPTO).
• Reissue applications and reexamination proceedings are also excluded from this provision.
• Provisional applications and international applications that have not entered the U.S. national stage are also excluded.

Filing Requirements That Can’t Be Missed

The request for prioritized examination (USPTO Form PTO/AIA/424) and all Track 1 fees must be submitted at the time of filing (or with an RCE). You cannot request Track 1 after the application has already been examined or if a first Office Action has been issued.

If any required element, such as the filing, search, and examination fees, is missing at filing, the Track 1 request will be dismissed, and the delay can jeopardize the expedited timeline.

Utility applications with a Track 1 request must be filed electronically through the USPTO’s Patent Center. Paper filings of utility applications are not eligible for prioritized examination.

Track 1 Fees: Investment vs. Return Analysis

Since January 19, 2025, the Track 1 fee is $4,515 for large entities, with 60% and 80% discounts for small and micro entities ($1,806 and $903), plus a processing fee and the standard filing fees (USPTO fee schedule). This represents a substantial upfront investment that demands strategic justification.

Current Fee Structure

*Track 1 fee plus the $150, $60, or $30 processing fee, on top of standard filing, search, and examination fees.

ROI Considerations: When Track 1 Pays

The investment often generates returns through:

Opportunity Cost Avoidance: For a startup, an issued patent could be the key to unlocking a funding round or licensing deal now, rather than later. If a patent would enable a significant revenue opportunity or competitive advantage in that year, the Track 1 fee may be trivial by comparison.

Reduced Prosecution Costs: Faster resolution often means fewer Office Action cycles, and each cycle you avoid saves attorney fees.

Strategic Patent Strength: Additionally, there is a potential quality/strength benefit. Track 1 often results in “cleaner” patents with fewer arguments estopping claim scope. A patent with a short, compact prosecution history may be stronger in litigation.

At Rapacke Law Group, we offer Track 1 filing with transparent, fixed-fee pricing – no surprises from hourly billing. You’ll know exactly what your investment is upfront, allowing you to make informed strategic decisions about whether Track 1 makes sense for your specific situation.

Track 1 Application Process: Step-by-Step Execution

Filing Track 1 requires precision – procedural errors can derail expedited status and cost valuable time.

Filing Timeline and Expectations

After filing, the Office of Petitions reviews the Track 1 request. In fiscal year 2026, the USPTO took about 2 months on average from filing to grant prioritized status (USPTO Track One dashboard).

Once granted, the acceleration begins immediately:

• First Office Action: about 1.6 months after the Track 1 grant (about 3.7 months from filing) in fiscal year 2026, compared to 20.5 months for a first action on a regular application.
• Final Disposition: about 4.9 months after the Track 1 grant, with allowances coming 4.2 months after the grant on average (12-month goal), whereas regular applications averaged 28.8 months of total pendency.

What Happens After Track 1 Status is Granted

Once the USPTO grants prioritized status, several immediate changes occur in the prosecution process:

Priority Docketing: The application moves to the examiner’s special “Track 1” docket, ahead of all regular new cases. Examiners are given goals to act on Track 1 cases quickly at each stage.

Accelerated Communications: Office Actions on Track 1 applications are issued more quickly, often back-to-back, within weeks of receiving responses. Examiner interviews, if requested, are scheduled promptly.

Enhanced Prosecution Engagement: Interviews are especially useful in Track 1, because resolving an issue in one call can save a full Office Action cycle.

Success Rates: Track 1 Performance Data

The USPTO’s own statistics show how Track 1 applications fare.

Allowance Rates

The USPTO reports an overall allowance rate of about 79% for fiscal year 2026, counting applications that continue through an RCE as still pending rather than abandoned (USPTO Patents Dashboard). It does not publish a matching allowance rate for Track 1. Its Track 1 data for fiscal year 2026 show 9,123 allowances, 5,432 final rejections, and 616 abandonments among final dispositions (USPTO Track One dashboard); a final rejection is not always the end, since an applicant can file an RCE with a new Track 1 request.

Program Volume and Capacity

The annual program capacity is 20,000 applications per year (raised from 15,000 in 2025 due to demand). In FY2024, over 15,000 Track 1 requests were filed, surpassing the previous annual cap and demonstrating strong demand.

Despite this growth, Track 1 filings still represent a single-digit percentage of overall U.S. patent applications, so the program remains a specialized route for selected cases.

Technology Sector Distribution

The USPTO does not publish a breakdown of Track 1 requests by technology, but use tends to follow product cycles. Drug makers use it heavily (see the JAMA study below), and so do fast-moving technology companies.

Software and consumer electronics operate on rapid product cycles – obtaining a patent quickly can be crucial before a technology becomes obsolete or widely adopted without protection. For more guidance on protecting software innovations, see our AI Patent Mastery and SaaS Patent Guide 2.0 resources.

Strategic Use Cases: When Track 1 Delivers Maximum Value

Pharmaceutical Strategic Timing

A recent study in JAMA Health Forum (July 2024) examined how pharmaceutical companies strategically leverage Track 1 to time their patent grants. In the pharma industry, new drugs get a period of FDA-granted exclusivity.

The study found that brand-name drug manufacturers frequently use Track 1 to obtain secondary patents just before the FDA exclusivity or primary patent expires, thereby delaying generic competition.

The timing data is striking: Track 1 patents (for biologics) tend to peak later (around 12–13 years after approval, coinciding with the end of the biologic’s exclusivity), whereas regular patents peak earlier. This suggests that drug companies intentionally utilize Track 1 to expedite patent applications during the brief window when regulatory exclusivity is set to expire.

Startup Funding and Investment

For startups, particularly in the tech and biotech sectors, patents are often crucial for securing venture capital. Investors view issued patents as a sign of a strong moat around the business.

A startup aiming for a Series A round in a year may file a Track 1 application for its core technology; by the time they pitch to VCs, they can show an issued patent rather than just a pending application. This tangible proof of IP ownership can increase valuation and investor confidence.

I’ve seen this strategy work repeatedly for our SaaS and AI clients. When you’re sitting across from potential investors with an issued patent protecting your core algorithm or platform architecture, the conversation changes. You’re not just selling potential – you’re demonstrating protected, defensible innovation.

Fast-Moving Technology Sectors

In industries like software, consumer electronics, or e-commerce, product cycles are extremely short. A patent that grants in 3 years might protect a technology that’s already obsolete or widely adopted by others.

Some companies also use Track 1 to obtain patents ahead of industry-standardization or interoperability milestones, allowing them to influence standards or require others to license their technology.

For AI and machine learning innovations, Track 1 is particularly strategic. The field evolves so rapidly that an algorithm breakthrough today might be standard practice in 18 months. Track 1 lets you secure protection while your innovation still delivers competitive differentiation.

Critical Product Launch Protection

If you know you will be launching a product and you worry about copycats, a Track 1 patent can arm you with enforceable rights near the product launch date. With Track 1, your patent might issue around the time of launch, so you can immediately warn competitors or file infringement suits if needed.

Track 1 vs. Alternative Expedited Options

Patent Prosecution Highway (PPH) Comparison

The PPH allows an allowed claim set in one jurisdiction (e.g., the U.S.) to fast-track corresponding applications in other countries. An applicant in a hurry globally might use Track 1 in the USPTO, obtain an allowance, and then leverage PPH to expedite the process in Europe, Japan, and other regions.

When to Choose Track 1 Over PPH:

• Limited international portfolio without foreign allowances.
• The need for a predictable U.S. timeline, regardless of foreign prosecution.
• Specific U.S. business deadlines that can’t wait for international coordination.

Other Expedited Programs

The USPTO has ended several other expedited routes in recent years: the COVID-19 pilot closed to new requests on May 11, 2023, the Climate Change Mitigation Pilot Program was terminated in 2025, and Accelerated Examination for utility applications ended on July 10, 2025. That makes Track 1 the primary avenue for speed now.

Some specialized options remain:

• Petitions to make special based on the inventor’s age (65 or older) or health, which carry no fee (37 C.F.R. § 1.102(c)).
• Patent Prosecution Highway requests, when a partner patent office has already found claims allowable.

What Happened to Prioritized Examination for COVID-19 Inventions?

The USPTO’s COVID-19 Prioritized Examination Pilot Program gave small and micro entities Track One examination for free on COVID-19 inventions. It took effect on May 14, 2020, and closed to new requests on May 11, 2023. A COVID-related drug, diagnostic, or medical device invention now goes through regular Track 1, at the reduced small or micro entity fee if you qualify. While it ran, the pilot:

• Waived the Track One fee and processing fee; basic filing, search, and examination fees still applied.
• Required small or micro entity status and at least one claim to a COVID-19 product or process subject to an FDA approval for COVID-19 use, such as an Emergency Use Authorization (EUA), Investigational Device Exemption (IDE), or Premarket Approval (PMA).
• Used the Track One claim limits and was open to original utility and plant applications, applications claiming the benefit of one earlier nonprovisional or international application, and applications with a first prioritized RCE.
• Started with a cap on the number of applications, which the USPTO later removed. By June 4, 2024, 1,078 applications had been filed under the pilot and 708 had been granted prioritized status.

Track 1 Examination Procedures and Best Practices

Examiner Assignment and Quality

Track 1 cases are assigned to examiners just like typical cases, based on technology area (art unit) and subject matter, and the same quality checks apply to Track 1 actions as to any other examination.

Interview Strategy

One notable aspect of Track 1 is the ability (and need) to communicate efficiently with the examiner. The program encourages early interviews and interaction to resolve issues faster.

Many Track 1 applicants request an examiner interview before the first Office Action (a so-called pre-first-action interview). This can be done by contacting the examiner once the application appears on their docket.

Because the docket moves quickly, request an interview early rather than waiting for a second rejection.

Response Strategy

Responding to an Office Action in a Track 1 case is procedurally the same as in any application; however, given the time pressure, applicants often prioritize a compact prosecution. Filing responses well before the three-month deadline keeps the application moving.

Examiners in Track 1 are often more willing to initiate examiner’s amendments or call the attorney to suggest allowable subject matter, since they know the clock is ticking.

Strategic Decision Framework: Should You File Track 1?

High-Value Scenarios

Market Timing Is Critical: When Speed to Patent Directly Impacts Competitive Positioning or Market Entry Timing.

Investment/Partnership Dependent: When issued patents (as opposed to pending applications) significantly impact funding, valuation, or partnership opportunities.

Enforcement Timeline Sensitive: When earlier patent issuance enables a faster response to infringement or facilitates licensing negotiations.

Standards/Specification Deadlines: When patents need to issue before industry standards are finalized or specifications are adopted.

Cost-Benefit Analysis Framework

Consider these factors:

1. Opportunity Cost of Delay: What business opportunities depend on having issued patent protection within 12 months vs. 24-30 months?
2. Portfolio Strategy: Is this a crown jewel patent justifying premium fees, or would resources be better allocated across multiple standard applications?
3. Technology Lifecycle: Will the protected technology remain commercially relevant throughout the extended standard examination timeline?
4. Competitive Landscape: How quickly are competitors moving in the same technical space?

When to Avoid Track 1

Some applicants intentionally delay specific applications to keep options open or to extend the overall patenting timeline (patent pending status can sometimes be advantageous if you’re not ready to enforce). Track 1 removes that flexibility – it forces a conclusion, one way or another, within a year.

Avoid Track 1 when:

• Technology is still evolving, and claiming scope flexibility is a valuable asset.
• Budget constraints make the fees prohibitive in relation to the business value.
• No specific timeline pressures exist for the issuance of a patent.
• An international filing strategy depends on a delayed U.S. prosecution.

Your Next Steps to Track 1 Success

Track 1 prioritized examination represents a powerful strategic tool for tech startups and innovators who need patent protection aligned with business timelines. Whether you’re seeking funding, launching a product, or entering a competitive market, controlling when your patent issues can mean the difference between market leadership and playing catch-up.

The bottom line: weak or delayed patents help your competitors. When you secure strong patent protection at the right time, you deter competition, command higher valuations, and control your market position. Track 1 isn’t just about speed – it’s about strategic timing that maximizes your competitive advantage.

Here’s what’s at stake: every month you delay could mean lost investor confidence, missed partnership opportunities, or competitors copying your innovation with impunity. In fast-moving tech sectors, the first-to-file system rewards those who act decisively. Hesitation doesn’t just cost money – it costs market control, revenue opportunities, and competitive positioning that may never be recovered.

Your immediate action items:

1. Schedule a Free IP Strategy Call with our patent team to evaluate whether Track 1 makes sense for your specific innovation and business timeline.
2. Review your current product roadmap and funding timeline to identify patents where 12-month protection could deliver strategic value.
3. Download our SaaS Patent Guide 2.0 to understand how Track 1 fits into comprehensive IP protection strategies.
4. If you’re in AI/ML, explore our AI Patent Mastery resource for sector-specific Track 1 considerations.

The most successful startups don’t just innovate – they strategically protect their innovations. Proper Track 1 filing isn’t an expense; it’s an investment in competitive advantage that pays dividends through stronger market position, higher valuations, and protection that actually deters competitors when you need it most.

Don’t let standard examination timelines dictate your business strategy. Take control of your patent timing and transform USPTO processing from obstacle to accelerator.

The RLG Guarantee for Your Patent

When you work with Rapacke Law Group for your patent filing:

• FREE strategy call with the RLG team to determine if Track 1 is right for your innovation.
• Experienced US patent attorneys lead your application from start to finish.
• One transparent flat-fee covering your entire patent application process (including office actions).
• Full refund if USPTO denies your patent application*.
• Full refund or additional searches if your application has patentability issues (your choice)*.

*Terms and conditions apply. Contact us for details.

Andrew Rapacke is Managing Partner and a Registered Patent Attorney at Rapacke Law Group, specializing in software patents, AI innovations, and strategic IP protection for tech startups. Connect with Andrew on LinkedIn or follow @rapackelaw on Twitter/X and Instagram.

To Your Success,

Andrew Rapacke, Esq.
Managing Partner, Registered Patent Attorney
Rapacke Law Group

For the most current Track 1 fee schedules, forms, and filing procedures, consult the USPTO’s official Track 1 information page or contact Rapacke Law Group for personalized guidance on Track 1 strategic filing.